PharmacyCodes



Triamcinolonum [Inn] en es it fr

Categoria

Triamcinolonum [Inn] Nombres de marca, Triamcinolonum [Inn] Analogos

Triamcinolonum [Inn] Marca los nombres de mezcla

  • Aristoform R Crm 0.1% (Clioquinol + Triamcinolone Acetonide)
  • Derma-4 Ont (Neomycin Sulfate + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Kenacomb Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Mecomb Crm 0.1% (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Oribiotic Ointment (Bacitracin + Lidocaine + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Panolog Cream (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Panolog Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Ratio-Triacomb Regular Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Solvaderm Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Theraderm Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Crm (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)

    • Triamcinolonum [Inn] Formula quimica

    C21H27FO6

    Triamcinolonum [Inn] RX enlace

    http://www.rxlist.com/cgi/generic/triamaer.htm

    Triamcinolonum [Inn] FDA hoja

    Triamcinolonum_[Inn] FDA

    Triamcinolonum [Inn] MSDS (hoja de seguridad de materiales)

    Triamcinolonum_[Inn] MSDS

    Triamcinolonum [Inn] Sintesis de referencia

    Fried et al., J. Am. Chem. .. Soc. 80, 2338 (1958)

    Triamcinolonum [Inn] Peso molecular

    394.434 g/mol

    Triamcinolonum [Inn] Punto de fusion

    274 - 278 (dec) oC

    Triamcinolonum [Inn] H2O Solubilidad

    80 mg / L

    Triamcinolonum [Inn] Estado

    Solid

    Triamcinolonum [Inn] LogP

    0.329

    Triamcinolonum [Inn] Formas de dosificacion

    Crema, líquido, los inhaladores de dosis (aerosol), ungüento, pasta, suspensión, jarabe, Tablet

    Triamcinolonum [Inn] Indicacion

    Para el tratamiento de la rinitis alérgica perenne y estacional.

    Triamcinolonum [Inn] Farmacologia

    Triamcinolona y sus derivados son glucocorticoides sintéticos que se utilizan por sus propiedades antiinflamatorias o inmunosupresoras.

    Triamcinolonum [Inn] Absorcion

    Rápida absorción tras la administración oral

    Triamcinolonum [Inn] Toxicidad

    LD50 => 500mg/kg (en ratas)

    Triamcinolonum [Inn] Informacion de Pacientes

    Patients being treated with Azmacort Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a complete disclosure of all possible adverse or intended effects.

    Patients should use Azmacort Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicate that significant improvement in asthma may occur by 1 week, but maximum benefit may not be achieved for 2 weeks or more. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.

    In clinical studies and post-marketing experience with Azmacort Inhalation Aerosol, local infections of the oropharynx with Candida albicans have occurred. When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while remaining on treatment with Azmacort Inhalation Aerosol. However, at times therapy with Azmacort Inhalation Aerosol may need to be interrupted.

    Patients should be instructed to track their use of Azmacort Inhalation Aerosol and to dispose of the canister after 240 actuations since reliable dose delivery cannot be assured after 240 doses.

    Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles and if exposed, to obtain medical advice.

    Triamcinolonum [Inn] Organismos afectados

    Humanos y otros mamíferos